Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Taxane Refractory Prostate Cancer
Paul Mathew,
Robert DiPaola
Internal Medicine
College of Medicine
University of Kentucky
Provost
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Taxane Refractory Prostate Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Prostate Cancer
100%
Therapeutic Procedure
80%
Microtubule
40%
Docetaxel
40%
Development
20%
Diseases
20%
Comprehension
20%
Drug
20%
Mechanism of Action
20%
Clinical Trial
20%
Antineoplastic Activity
20%
Consensus
20%
Cellular Mechanism
20%
Castration Resistant Prostate Cancer
20%
Mitosis Spindle
20%
Cytotoxic Agent
20%
Satraplatin
20%
Stromal Tumor
20%
Neurotoxicity
20%
Drug Resistance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Taxane
100%
Prostate Cancer
100%
Docetaxel
28%
Neurotoxicity
14%
Clinical Trial
14%
Antitumor Activity
14%
Drug
14%
Castration Resistant Prostate Cancer
14%
Cytotoxic Agent
14%
Satraplatin
14%
Disease
14%
Neoplasm
14%
Drug Resistance
14%